Centor manufactures the industry-standard Screw-Loc child-resistant package and the 1-Clic vial, which emits an audible click to ensure proper closing. The deal will expand Gerresheimer's footprint in the U.S. pharma packaging market.
"[The acquisition] is a perfect fit to extend our product offering from packaging of parenterals to the packaging of oral drugs in the United States," said Gerresheimer CEO Uwe Röhrhoff in a prepared statement. "We expect that this acquisition will increase shareholder value significantly."
Subject to regulatory approval, the acquisition is expected to close in the fourth quarter of 2015. Centor will be integrated in the plastics and devices division of Gerresheimer.